RXRα represents an intriguing and unique target for pharmacologic interventions. We recently showed that Sulindac and a designed analog could bind to RXRα and modulate its biological activity, including inhibition of the interaction of an N-terminally truncated RXRα (tRXRα) with the p85α regulatory subunit of phosphatidylinositol-3-OH kinase (PI3K). Here we report the synthesis, testing and SAR of a series of novel analogs of Sulindac as potential modulators for inhibiting tRXRα-dependent AKT activation. A new compound 30 was identified to have improved biological activity.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3738195 | PMC |
| http://dx.doi.org/10.1016/j.ejmech.2013.01.012 | DOI Listing |
Publication Analysis
Top Keywords
modulators inhibiting
8
inhibiting trxrα-dependent
8
trxrα-dependent akt
8
akt activation
8
biological activity
8
synthesis sar
4
sar study
4
study modulators
4
activation rxrα
4
rxrα represents
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!